Las Vegas, NV -- (SBWIRE) -- 10/08/2013 -- PennyStockParlay.com Our process for picking penny stocks is not only unconventional, but untapped, undiscovered, and also exclusive. To keep our picks consistent with how only the "Best Penny Stocks" perform in the penny stock market, we have to keep our penny stock picks producing large and consistent gains.Have a look at today’s active stocks: Trans Global Group Inc(OTCMKTS:TGGI), Medisafe 1 Technologies Corp(OTCBB:MFTH), THERAPY CELLS INC(OTCMKTS:TCEL), Affymax, Inc.(OTCMKTS:AFFY)
Trans Global Group Inc(OTCMKTS:TGGI) reported gain 200% and closed at $0.0003 with the total traded volume of 546.12M shares. Its market capitalization is $ 1.07M. The stock has a 52-week high price of $0.0004 and its 52-week low was recorded at $0.0002
Trans Global Group Inc. are engaged in direct dial international long-distance service from the United States for commercial customers through two switches owned and operated in Kansas and Las Vegas.
What TGGI Charts Are Signaling for Traders? Find Out Here
Medisafe 1 Technologies Corp(OTCBB:MFTH) gain 11.11% and ended at $0.0010.The total traded volume was 155.61M shares and market capitalization arrived at $867287. The stock has a 52-week high price of $0.01 and its 52-week low was recorded at $0.00
Medisafe 1 Technologies Corp (Medisafe 1 Technologies) is a development-stage Company. The Company is a medical assembly, which prevents unauthorized administration of a drug or medicinal substance by hypodermic needle.
Is MFTH Buy After The Recent Price Movement? Find Out Here
THERAPY CELLS INC(OTCMKTS:TCEL)’s reported loss -41.18% and close at $0.0020 with the overall traded volume of 23.58M shares. Its market capitalization on last close reached to $262800. Its intraday-low price was $0.0015 and its hit its day's highest price at $0.05.
Should TCEL a Buy or Sell Now? Find Out Here
Affymax, Inc.(OTCMKTS:AFFY) loss -2.33% and settle at $1.26. Its total traded volume during last trading session was 307542 shares. The overall market worth of this company is about $47.24M. The 52 week range of the stock remained $0.78 - $27.74
Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis.
What AFFY Charts Are Signaling for Traders? Find Out Here
Penny stocks are stocks that can be traded in the stock market at a very cheap price. The investor who decides to buy penny stocks should have a substantial intellect of the market and should be bequeathing to possibly suffer a loss in money. The phrase penny stock is usually used for stock dealing that does not imply the greater and popularly known exchanges.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the PennyStockParlay.comnewsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
PennyStockParlay.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your investment manager before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies in the profiled on the PennyStockParlay.com web site and/or newsletter involve a high degree of risk and volatility, and all investors should know that they may lose a portion or all of their investment if they decide to purchase any stock.
Read Full Disclaimer at: http://pennystockparlay.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)